We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+31.97%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.12B
AUM Growth
-$319M
(-22%)
Cap. Flow
-$563M
Cap. Flow
% of AUM
-50.08%
Top 10 Holdings %
Top 10 Hldgs %
21.26%
Holding
360
New
82
Increased
64
Reduced
136
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$15.3M |
| 2 |
Broadridge
BR
|
+$13.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$11.1M |
| 4 |
Dominion Energy
D
|
+$10.6M |
| 5 |
NextEra Energy
NEE
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CORE
Core Mark Holding Co., Inc.
CORE
|
+$34M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
+$26.8M |
| 3 |
Rio Tinto
RIO
|
+$26.3M |
| 4 |
TriMas Corp
TRS
|
+$23.6M |
| 5 |
Texas Instruments
TXN
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.12% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14% |
| 4 | Industrials | 10.81% |
| 5 | Healthcare | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ares Capital
ARCC
$13.5B
| $2.61M | 0.23% |
180,541
-21,496
| -11% | -$290K |
|
102
Snap-on
SNA
$20.9B
| $2.44M | 0.22% |
17,614
-3,553
| -17% | -$451K |
|
103
Main Street Capital
MAIN
$4.97B
| $2.36M | 0.21% |
75,787
-12,253
| -14% | -$345K |
|
104
Hercules Capital
HTGC
$2.94B
| $2.35M | 0.21% |
224,546
-23,730
| -10% | -$241K |
|
105
Sixth Street Specialty
TSLX
$1.59B
| $2.27M | 0.2% |
137,854
+936
| +0.7% | +$15.6K |
|
106
EverQuote
EVER
$886M
| $2.26M | 0.2% |
38,871
+17,178
| +79% | +$807K |
|
107
CDW
CDW
$17.1B
| $2.26M | 0.2% |
19,434
-2,552
| -12% | -$276K |
|
108
Ascendis Pharma A/S
ASND
$16.7B
| $2.14M | 0.19% |
14,467
+1,204
| +9% | +$165K |
|
109
Golub Capital BDC
GBDC
$3.33B
| $2.12M | 0.19% |
181,533
+18,330
| +11% | +$206K |
|
110
RH
RH
$3.3B
| $2.08M | 0.19% |
8,376
+3,086
| +58% | +$559K |
|
111
NovoCure
NVCR
$2.04B
| $1.98M | 0.18% |
33,372
-3,934
| -11% | -$259K |
|
112
Meritage Homes
MTH
$4.87B
| $1.92M | 0.17% |
50,490
+23,928
| +90% | +$707K |
|
113
Amgen
AMGN
$203B
| $1.92M | 0.17% |
8,131
-1,621
| -17% | -$370K |
|
|
AYX
114
DELISTED
Alteryx Inc
AYX
| $1.89M | 0.17% |
11,483
+8,096
| +239% | +$1.05M |
|
115
Inspire Medical Systems
INSP
$1.42B
| $1.86M | 0.17% |
21,381
-9,389
| -31% | -$722K |
|
116
SiteOne Landscape Supply
SITE
$4.43B
| $1.86M | 0.17% |
16,299
+1,513
| +10% | +$141K |
|
117
UFP Industries
UFPI
$4.97B
| $1.86M | 0.17% |
+37,479
| New | +$1.6M |
|
118
New Mountain Finance
NMFC
$646M
| $1.85M | 0.16% |
198,993
-2,829
| -1% | -$23.2K |
|
119
Winnebago Industries
WGO
$870M
| $1.77M | 0.16% |
+26,626
| New | +$1.36M |
|
120
PennyMac Financial
PFSI
$4.38B
| $1.77M | 0.16% |
42,335
+7,337
| +21% | +$232K |
|
121
Barings BDC
BBDC
$862M
| $1.76M | 0.16% |
222,028
+66,552
| +43% | +$478K |
|
122
SLR Investment Corp
SLRC
$706M
| $1.67M | 0.15% |
104,438
-26,770
| -20% | -$407K |
|
123
Lattice Semiconductor
LSCC
$17.6B
| $1.64M | 0.15% |
57,738
-3,065
| -5% | -$71.6K |
|
124
Schrodinger
SDGR
$1.12B
| $1.64M | 0.15% |
17,852
+4,770
| +36% | +$278K |
|
125
Oaktree Specialty Lending
OCSL
$1.03B
| $1.63M | 0.14% |
121,294
+7,853
| +7% | +$97.7K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q2 2020 Portfolio in Review
As of Q2 2020, Advisory Research held 360 positions worth $1.12B, down 22% from $1.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Advisory Research withdrew a net $563M in Q2 2020, closing 54 positions and reducing 136 holdings. Its most notable exit was Chunghwa Telecom, an estimated $18.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Advisory Research opened a new position in AbbVie worth $17M.
- Advisory Research's largest Q2 2020 buy was AbbVie: 173,370 shares worth $17M.
- Advisory Research added most to Motorola Solutions in Q2 2020, an estimated $5.55M increase.
- Advisory Research's biggest Q2 2020 reduction was Core Mark Holding Co., Inc., cutting an estimated $34M.
- Advisory Research fully exited Chunghwa Telecom in Q2 2020, selling an estimated $18.4M.
- Advisory Research's ten largest holdings make up 21% of its $1.12B portfolio in Q2 2020.
- Advisory Research opened 82 new positions and closed 54 in Q2 2020.
- Advisory Research's portfolio value fell 22% quarter-over-quarter to $1.12B.
Based on Advisory Research's 13F filing for Q2 2020, filed 13 Aug 2020.